Literature DB >> 17160051

Reinventing phage therapy: are the parts greater than the sum?

Vincent A Fischetti1, Daniel Nelson, Raymond Schuch.   

Abstract

Although whole phage continue to generate interest as an alternative to antibiotics, focus is shifting to the use of purified phage components as antibacterial agents.

Mesh：

Substances：

Year:  2006        PMID： 17160051     DOI： 10.1038/nbt1206-1508

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


  55 in total

1.  Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus.

Authors:  Jun Taek Oh; Cara Cassino; Raymond Schuch
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms.

Authors:  R Briandet; P Lacroix-Gueu; M Renault; S Lecart; T Meylheuc; E Bidnenko; K Steenkeste; M-N Bellon-Fontaine; M-P Fontaine-Aupart
Journal:  Appl Environ Microbiol       Date:  2008-02-01       Impact factor: 4.792

Review 3.  Novel approaches to developing new antibiotics for bacterial infections.

Authors:  A R M Coates; Y Hu
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

Review 4.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Influence of some environmental variables and addition of r-lysozyme on efficacy of Vibrio harveyi phage for therapy.

Authors:  Tanmoy Gon Choudhury; Biswajit Maiti; M N Venugopal; Indrani Karunasagar
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

6.  X-ray crystal structure of the streptococcal specific phage lysin PlyC.

Authors:  Sheena McGowan; Ashley M Buckle; Michael S Mitchell; James T Hoopes; D Travis Gallagher; Ryan D Heselpoth; Yang Shen; Cyril F Reboul; Ruby H P Law; Vincent A Fischetti; James C Whisstock; Daniel C Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-17       Impact factor: 11.205

7.  A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.

Authors:  Rolf Lood; Assaf Raz; Henrik Molina; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

8.  In silico and in vivo evaluation of bacteriophage phiEF24C, a candidate for treatment of Enterococcus faecalis infections.

Authors:  Jumpei Uchiyama; Mohammad Rashel; Iyo Takemura; Hiroshi Wakiguchi; Shigenobu Matsuzaki
Journal:  Appl Environ Microbiol       Date:  2008-05-02       Impact factor: 4.792

9.  Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

Authors:  Anu Daniel; Chad Euler; Mattias Collin; Peter Chahales; Kenneth J Gorelick; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

10.  Functional genomic analysis of two Staphylococcus aureus phages isolated from the dairy environment.

Authors:  Pilar García; Beatriz Martínez; José María Obeso; Rob Lavigne; Rudi Lurz; Ana Rodríguez
Journal:  Appl Environ Microbiol       Date:  2009-10-16       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.